GSK moves on Sirtris
news article · 2008
LINK
SUMMARY
Trade-press news item confirming GlaxoSmithKline's announced (22 April 2008) $720 million acquisition of Sirtris Pharmaceuticals of Cambridge, Massachusetts, and the 84% premium on Sirtris's outstanding shares; independently corroborates the New York Times report of the same transaction terms.
NOTES
Corroborating source for the Sirtris/GSK acquisition terms, used alongside the New York Times report since the Times page could not be directly re-fetched in this session.